1. Home
  2. RGEN vs BIRK Comparison

RGEN vs BIRK Comparison

Compare RGEN & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$166.48

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Logo Birkenstock Holding plc

BIRK

Birkenstock Holding plc

HOLD

Current Price

$41.30

Market Cap

8.8B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGEN
BIRK
Founded
1981
1774
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
8.8B
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
RGEN
BIRK
Price
$166.48
$41.30
Analyst Decision
Buy
Strong Buy
Analyst Count
10
12
Target Price
$174.90
$65.50
AVG Volume (30 Days)
617.0K
3.0M
Earning Date
02-19-2026
12-18-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
83.10
EPS
0.03
2.19
Revenue
$707,890,000.00
$2,460,904,611.00
Revenue This Year
$17.84
$14.52
Revenue Next Year
$12.44
$14.40
P/E Ratio
$6,513.01
$18.80
Revenue Growth
11.74
16.22
52 Week Low
$102.97
$38.16
52 Week High
$182.52
$62.66

Technical Indicators

Market Signals
Indicator
RGEN
BIRK
Relative Strength Index (RSI) 58.72 43.68
Support Level $161.41 $41.98
Resistance Level $167.65 $43.02
Average True Range (ATR) 4.54 1.70
MACD 0.16 -0.45
Stochastic Oscillator 89.26 15.21

Price Performance

Historical Comparison
RGEN
BIRK

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About BIRK Birkenstock Holding plc

Birkenstock Holding PLC is a company that manufactures and sells footbed-based products, including sandals, closed-toe silhouettes, and other products, such as skincare and accessories, for everyday, leisure, and work. It sells its products through two main channels: business-to-business (B2B) which comprises sales made to established third-party store networks, and direct-to-consumer (DTC) which comprises sales made on globally owned online stores through the Birkenstock.com domain and sales made in Birkenstock retail stores. The company's reportable segments are based on its regional hubs and include: the Americas which is also its key revenue-generating segment; Europe; and Australia, Japan, India, China, and the United Arab Emirates (APMA).

Share on Social Networks: